Lexicon Pharmaceuticals Inc. diskutieren
Lexicon Pharmaceuticals Inc.
WKN: A14SSK / Symbol: LXRX / Name: Lexicon PHARM / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,71 €
16,47 %
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $5.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Neueste Beiträge
HC_Wainwright in My Size Inc diskutieren